HUMAN C1-ESTERASE INHIBITOR for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where HUMAN C1-ESTERASE INHIBITOR was used for Immunodeficiency common variable.
Most Reported Side Effects for HUMAN C1-ESTERASE INHIBITOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hereditary angioedema | 5,572 | 38.9% | 26 | 1,443 |
| No adverse event | 1,660 | 11.6% | 59 | 267 |
| Off label use | 1,614 | 11.3% | 808 | 964 |
| Drug ineffective | 1,426 | 9.9% | 520 | 745 |
| Intentional product use issue | 1,117 | 7.8% | 534 | 566 |
| Product use in unapproved indication | 1,003 | 7.0% | 502 | 518 |
| Weight increased | 897 | 6.3% | 422 | 526 |
| Maternal exposure during pregnancy | 869 | 6.1% | 583 | 525 |
| Pain | 822 | 5.7% | 502 | 562 |
| Condition aggravated | 775 | 5.4% | 527 | 505 |
| Swelling | 737 | 5.1% | 523 | 541 |
| Fatigue | 716 | 5.0% | 458 | 507 |
| Nausea | 715 | 5.0% | 408 | 459 |
| Headache | 712 | 5.0% | 384 | 451 |
| Product use issue | 701 | 4.9% | 309 | 415 |
Other Indications for HUMAN C1-ESTERASE INHIBITOR
Hereditary angioedema (10,446)
Prophylaxis (5,950)
Product used for unknown indication (1,992)
Immune system disorder (387)
Hereditary angioedema with c1 esterase inhibitor deficiency (373)
Hereditary angioedema with normal c1 esterase inhibitor (244)
Angioedema (187)
Complement factor abnormal (69)
Foetal exposure during pregnancy (61)
Off label use (61)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
MYCOPHENOLATE MOFETIL (24)